CVS Health Corporation $CVS Shares Acquired by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC increased its position in shares of CVS Health Corporation (NYSE:CVS) by 2,155.5% during the third quarter, Holdings Channel reports. The institutional investor owned 17,548 shares of the pharmacy operator’s stock after buying an additional 16,770 shares during the quarter. Elevation Point Wealth Partners LLC’s holdings in CVS Health were worth $1,323,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CVS. National Pension Service boosted its holdings in shares of CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after buying an additional 119,189 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock worth $7,873,000 after acquiring an additional 79,340 shares in the last quarter. AE Wealth Management LLC lifted its position in CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after acquiring an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock valued at $16,971,000 after acquiring an additional 22,653 shares in the last quarter. Finally, Alpha Omega Wealth Management LLC boosted its stake in CVS Health by 12.3% in the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of research analyst reports. Mizuho lifted their target price on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Sanford C. Bernstein raised CVS Health from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $91.00 to $94.00 in a report on Thursday, March 12th. Finally, Bank of America lowered their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $95.05.

CVS Health Stock Down 0.4%

CVS Health stock opened at $75.81 on Tuesday. The stock has a 50 day moving average of $78.08 and a two-hundred day moving average of $77.85. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The stock has a market capitalization of $96.45 billion, a price-to-earnings ratio of 54.94, a PEG ratio of 0.79 and a beta of 0.49. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same quarter in the previous year, the company posted $1.19 earnings per share. The company’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.